<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Erin Dorgan

Senior Analyst, Spine and OrthoBiologics

Orthobiologics

NASS Biologic Interventions 2025: Spotlight on Theradaptive

Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protei...

Orthopedics

Musculoskeletal New Ventures Conference 2025

The Musculoskeletal New Ventures Conference meeting offers a glimpse into emerging and promising technol...

Orthobiologics

Cerapedics: Innovation in Bone Growth Acceleration

Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide En...

Orthopedics

2025 NASS Innovation NetWORK Summit

NASS Executive Director and CEO Eric Muehlbauer discusses NASS’s new Innovation NetWORK Summit in an int...

Spine

Spinal Simplicity: Innovation in MIS Treatments Improving Patient Care

Spinal Simplicity’s Chief Strategy Officer Neil P. Dougherty shares how the company is advancing minimal...

Orthopedics

NASS Biologic Interventions 2025: Spotlight on Allumin8

Allumin8 CEO Alyssa Huffman discusses the company's novel therapeutic hardware during an interview with ...

Orthopedics

Clinical Evidence Poised to Redefine the Bone Replacement Market in 2025 and Beyond

SmartTRAK discusses key products and compelling clinical evidence that may impact the Bone Replacement M...

Orthopedics

Bone Replacement Trends for 2025

SmartTRAK will be attending AAOS 2025 this week. Join us at AAOS to explore our solution and discuss our...

Orthopedics

Musculoskeletal New Ventures Conference 2024

New spine technologies "pushed the envelope" at MNVC The Musculoskeletal New Ventures Conference (MNVC) ...

Spine

NASS 2024: Highlights from the Annual Meeting in Chicago

New products and clinical data continue to grow the spinal hardware and bone replacement markets. The No...